Galvenais jauno ideju un izgudrojumu \u0123ener\u0113t\u0101js farm\u0101cijas jom\u0101 Latvij\u0101 ir Organisk\u0101s sint\u0113zes instit\u016bts (OSI). Savuk\u0101rt z\u0101\u013cu ra\u017eot\u0101ja a\/s Grindeks darb\u012bbas pamatvirziens ir Latvij\u0101 izgudrotu ori\u0123in\u0101lz\u0101\u013cu komercializ\u0113\u0161ana.<\/p>\n\n\n\n
Galvenais izgudrojumu un patentu \u0123ener\u0113t\u0101js farm\u0101cijas jom\u0101 ir OSI. Grindek\u0101<\/em> nop\u0113rkam no OSI fizisko personu patentu un att\u012bst\u0101m. M\u0113s savuk\u0101rt patent\u0113jam industri\u0101l\u0101s izstr\u0101dnes \u2013 z\u0101\u013cu formas utt.,\u201d st\u0101sta Grindeka<\/em> Akt\u012bvo farmaceitisko vielu biznesa strukt\u016brvien\u012bbas direktors Vit\u0101lijs Skr\u012bvelis. Pasaul\u0113 OSI paz\u012bst<\/strong><\/p>\n\n\n\n To, ka OSI izgudrojumu un ar\u012b patentu ir daudz, ar lepnumu atz\u012bst ar\u012b instit\u016bta direktors akad\u0113mi\u0137is Ivars Kalvi\u0146\u0161. Vi\u0146\u0161 uzsver, ka OSI ir orient\u0113ts uz z\u0101\u013cu rad\u012b\u0161anu sirds un asinsvadu slim\u012bb\u0101m, uz pretv\u0113\u017ea, CNS un p\u0113d\u0113j\u0101 laik\u0101 ar\u012b uz pretv\u012brusu prepar\u0101tiem. \u201cM\u0113s neko citu nera\u017eojam k\u0101 zin\u0101tniskas idejas un drusku apstiprino\u0161as vieli\u0146as pa 100 mililitriem pudel\u012bt\u0113.\u201d Idejas un vieli\u0146as ra\u017eojot, OSI p\u0113c apgroz\u012bjuma k\u013cuvis par tre\u0161o liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu Baltij\u0101. Instit\u016bt\u0101 ir 300 darbinieki, no tiem 115 ir zin\u0101t\u0146u doktori. Krietni jaud\u012bgs, ja t\u0101 var teikt.<\/p>\n\n\n\n Tom\u0113r liel\u0101k\u0101 da\u013ca OSI p\u0113t\u012bjumu tiek, veikta p\u0113c \u0101rzemju firmu pas\u016bt\u012bjuma. \u201cPasaul\u0113 OSI brendu paz\u012bst,\u201d saka direktors. \u201c\u0100rzemju firmas samaks\u0101 par darbu un pret\u012b dab\u016b izgudrojumu. Pievienot\u0101 v\u0113rt\u012bba izgudrojumam ir t\u016bksto\u0161 rei\u017eu liel\u0101ka pret ieguld\u012bto. Runa ir par simtiem miljonu. T\u0101das v\u0113rt\u012bbas m\u0113s atdodam,\u201d valsts attieksmi kritiz\u0113 I. Kalvi\u0146\u0161.<\/p>\n\n\n\n \u201cIzgudro\u0161ana ir viena lieta, bet, lai aizst\u0101v\u0113tu to, ko esi izgudrojis, tur vajag naudu. Neviens nepirks novit\u0101ti, kas neb\u016bs aizst\u0101v\u0113ta no konkurentiem. Pret to aizst\u0101v tikai patents. Latvij\u0101 pieteikt patentu nav liela gudr\u012bba, un tas nemaks\u0101 d\u0101rgi \u2013 da\u017ei desmiti latu \u2013 to var katrs at\u013cauties. Bet Latvij\u0101 nav patentu ekspert\u012bzes, un l\u012bdz ar to j\u016bs neuzzin\u0101siet, vai tas ir t.s. pap\u012bra patents vai ar\u012b tas ir, ko v\u0113rts.<\/p>\n\n\n\n Latvij\u0101 tas aizsarg\u0101 tikm\u0113r, kam\u0113r uzrodas k\u0101ds un pasaka: \u201cZiniet, es to jau izgudroju pirms 10 gadiem.\u201d\u201d Savuk\u0101rt patenti ar visu ekspert\u012bzi ir \u013coti d\u0101rgi, piem\u0113ram, Eiropas centraliz\u0113tais patents maks\u0101 120 t\u016bkst. eiro. No idejas l\u012bdz tablet\u0113m<\/strong> Att\u012bst\u012bb\u0101 iegulda miljonus<\/strong> Dro\u0161ums ir j\u0101pier\u0101da Lai t\u0101 nenotiktu, Grindeks, liekot \u0137ie\u0123eli pa \u0137ie\u0123el\u012btim, b\u016bv\u0113 b\u0101zi, k\u0101 Latvij\u0101 \u0123ener\u0113t\u0101s jauno produktu idejas var k\u013c\u016bt par tirg\u016b p\u0101rdodam\u0101m z\u0101l\u0113m. \u201cEs Grindeka<\/em> biznesu redzu k\u0101 trijst\u016bri: aug\u0161\u0113j\u0101 da\u013ca ir ori\u0123in\u0101lprodukti, apak\u0161\u0113j\u0101 da\u013c\u0101 \u2013 akt\u012bv\u0101s vielas, kas tiek ra\u017eotas Grindek\u0101<\/em> speci\u0101li ori\u0123in\u0101lproduktiem.\u201d st\u0101sta V. Skr\u012bvelis. L\u012bdz\u0101s t\u0101m tiek ra\u017eotas ar\u012b p\u0113c patentu z\u0101les, lai klientiem var\u0113tu pied\u0101v\u0101t pilnu portfeli Grindeka<\/em> darb\u012bbas virzienos \u2013 kardiolo\u0123ij\u0101, neirolo\u0123ij\u0101, onkolo\u0123ij\u0101, psihotropij\u0101.<\/p>\n\n\n\n Grindek\u0101<\/em> ir sava jauno produktu izstr\u0101dnes komiteja, kas str\u0101d\u0101 ideju l\u012bmen\u012b \u2013 m\u0113nes\u012b ien\u0101kot ap 15 jaunu ideju, tiek veikti kl\u012bniskie p\u0113t\u012bjumi, tiek att\u012bst\u012bta anal\u012btisk\u0101 laboratorija, tom\u0113r liela da\u013ca p\u0113tniec\u012bbas ir \u0101rpakalpojumi. Galvenais sadarb\u012bbas partneris \u0161aj\u0101 jom\u0101 \u2013 OSI. \u201cPa\u0161iem j\u0101dara tikai tas, ko var labi dar\u012bt. M\u0113s labi dar\u0101m industri\u0101lo p\u0113tniec\u012bbu, k\u0101 ideju p\u0101rv\u0113rst par z\u0101l\u0113m, kas p\u0101rdodamas tirg\u016b,\u201d saka V. Skr\u012bvelis.<\/p>\n\n\n\n Tendence uzlaboties<\/strong> I. Kalvi\u0146\u0161 atz\u012bst, ka pirmo reizi kop\u0161 Latvijas neatkar\u012bbas kaut kas notiek pareiz\u0101 virzien\u0101, bet apjomi esot daudz par maziem, \u0146emot v\u0113r\u0101, ka farm\u0101cija un zin\u0101t\u0146ietilp\u012bg\u0101s nozares kopum\u0101 ir atz\u012btas par priorit\u0101r\u0101m. Vi\u0146apr\u0101t, nepareizi tiek sadal\u012bti ar\u012b simti miljoni ES naudas, kas paredz\u0113ta inov\u0101cij\u0101m. \u201cTur ir ielikts princips \u201cviens pieteic\u0113js \u2013 viens projekts\u201d. OSI, kas b\u016btu sp\u0113j\u012bgs pavilkt desmitiem projektu, b\u016bs spiests samierin\u0101ties ar vienu, un viena c\u016bku ferma ar\u012b var\u0113s pretend\u0113t uz vienu. \u0160ie principi noved\u012bs pie l\u012bdzek\u013cu iznieko\u0161anas.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":" Galvenais jauno ideju un izgudrojumu \u0123ener\u0113t\u0101js farm\u0101cijas jom\u0101 Latvij\u0101 ir Organisk\u0101s sint\u0113zes instit\u016bts (OSI). Savuk\u0101rt z\u0101\u013cu ra\u017eot\u0101ja a\/s Grindeks darb\u012bbas pamatvirziens ir Latvij\u0101 izgudrotu ori\u0123in\u0101lz\u0101\u013cu…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-211","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=211"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/211\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
A\/s Grindeks beidzamo tr\u012bs gadu darba rezult\u0101t\u0101 ir sagatavoti se\u0161i patenti un viens \u2013 nopirkts. V. Skr\u012bvelis \u0161aub\u0101s, vai LR Patentu valdes sarakst\u0101 (sk. tabulu) par Latvij\u0101 izsniegtajiem patentiem ir min\u0113ti visi, bet pie\u013cauj, ka da\u013ca nepar\u0101d\u0101s, jo 18 m\u0113ne\u0161i paiet no izgudrojuma iesnieg\u0161anas l\u012bdz patenta pie\u0161\u0137ir\u0161anai. \u201cSav\u0101di, ka OSI ir diezgan maz piere\u0123istr\u0113tu patentu, jo vi\u0146iem ideju ir \u013coti daudz.\u201d<\/p>\n\n\n\n
Citur valsts sektora izgudrojumu patent\u0113\u0161anu apmaks\u0101 valsts, Latvij\u0101 ne, saka instit\u016bta direktors. \u201c\u0160\u0101das poz\u012bcijas netiek paredz\u0113tas nedz zin\u0101tnes finans\u0113jum\u0101, nedz k\u0101dos grantos. T\u0101tad valsts zin\u0101tniekus nost\u0101da situ\u0101cij\u0101, ka vi\u0146i nevar aizst\u0101v\u0113t to, ko vi\u0146i ir izgudroju\u0161i.\u201d<\/p>\n\n\n\n
No mazliet cita aspekta uz ideju izmanto\u0161anu skat\u0101s a\/s Grindeks. Latvijas zin\u0101tnieki uz\u0146\u0113mumam m\u0113dzot p\u0101rmest: \u201cMums ir tik daudz ideju, j\u016bs vi\u0146as neizmantojat.\u201d Bet V. Skr\u012bvelis atg\u0101dina, ka no piln\u012bgi jaunas idejas l\u012bdz gatav\u0101m z\u0101l\u0113m ir vajadz\u012bgi 8 l\u012bdz 10 gadi un ap 800 milj. ASV dol\u0101ru.
Procesam ir vair\u0101kas da\u013cas. Pats s\u0101kums \u2013 ideja \u2013 n\u0101k no fundament\u0101l\u0101s zin\u0101tnes, da\u017ek\u0101rt no klienta. Otrs posms ir \u0161o z\u0101\u013cu rad\u012b\u0161ana. Tre\u0161ais posms \u2013 aizvest z\u0101li l\u012bdz klientam \u2013 tur ir kl\u012bniskie p\u0113t\u012bjumi, dro\u0161\u012bbas pier\u0101d\u012b\u0161ana utt. Tas ilgst vair\u0101kus gadus un maks\u0101 \u013coti daudz. P\u0113c kl\u012bniskajiem p\u0113t\u012bjumiem ir z\u0101\u013cu re\u0123istr\u0101cija. Jebkur\u0101 posm\u0101 var kaut kas noiet greizi. Bet, ja dab\u016b produktu l\u012bdz tirgum, tas ir liels pan\u0101kums,\u201d st\u0101sta Kintija Veisa, Grindeka <\/em>Biznesa att\u012bst\u012bbas strukt\u016bras direktore.<\/p>\n\n\n\n
Pa\u0161laik Grindeka <\/em>produktu portfel\u012b ir divi brendprodukti, 100 p\u0113c patenta produkti un 6 substances. Pavisam dr\u012bz vienam no veiksmes st\u016brakme\u0146iem \u2013 mildron\u0101tam \u2013 beigsies patenta aizsardz\u012bbas laiks. Vaic\u0101ts, vai zelta \u0101dere tad b\u016bs izsmelta, Grindeka <\/em>Akt\u012bvo farmaceitisko vielu biznesa strukt\u016brvien\u012bbas direktors Vit\u0101lijs Skr\u012bvelis nor\u0101da, ka uz\u0146\u0113mums jaunu produktu att\u012bst\u012bb\u0101 iegulda daudz \u2013 ap 10 % apgroz\u012bjuma, \u0161ogad vien ap 5 milj. Ls. \u0160aj\u0101 virzien\u0101 str\u0101d\u0101 75 \u2013 80 speci\u0101listi. \u201cNevar b\u016bt, ka tam neb\u016bs atdeves!\u201d vi\u0146\u0161 uzsver un nor\u0101da, ka Grindeka<\/em> m\u0113r\u0137is ir atjaunot portfeli un iziet starptautiskajos tirgos, pirm\u0101m k\u0101rt\u0101m Eirop\u0101, lai p\u0113c 5 \u2013 6 gadiem portfel\u012b b\u016btu 5 l\u012bdz 6 ori\u0123in\u0101lprepar\u0101ti, 50 p\u0113c patenta produkti un 20 substances.<\/p>\n\n\n\n
<\/strong>V. Skr\u012bvelis uzsver, ka Grindeka<\/em> darb\u012bbas pamatvirziens ir Latvij\u0101 izgudrotu ori\u0123in\u0101lz\u0101\u013cu komercializ\u0113\u0161ana. \u201cTas noz\u012bm\u0113 novest l\u012bdz st\u0101voklim, k\u0101ds ir pie\u0146emts pasaul\u0113 dokument\u0101cijas, efektivit\u0101tes, kvalit\u0101tes un dro\u0161uma pier\u0101d\u012b\u0161anas jom\u0101s.\u201d Pasaul\u0113 beidzamajos divos gados ir biju\u0161i divi skandalozi gad\u012bjumi, kad, nepiev\u0113r\u0161ot pietiekami lielu uzman\u012bbu prepar\u0101ta dro\u0161umam, izstr\u0101d\u0101t\u0101ji ir cietu\u0161i milz\u012bgus zaud\u0113jumus, min V. Skr\u012bvelis. Pirmais ir Bayer <\/em>holester\u012bnu samazino\u0161s prepar\u0101ts Lipobay<\/em>, kuram jau bija pabeigti kl\u012bniskie p\u0113t\u012bjumi, tas bija piere\u0123istr\u0113ts. 300 t\u016bkst. lietoja, 20 nomira. Firma zaud\u0113ja 4 mljrd. ASV dol\u0101ru. L\u012bdz\u012bgi notika ar Merck&Co<\/em> izstr\u0101d\u0101to Vioxx<\/em>. Saist\u012bb\u0101 ar \u0161iem diviem gad\u012bjumiem dro\u0161\u012bbas pras\u012bbas jaunajiem produktiem esot krasi pieaugu\u0161as.<\/p>\n\n\n\n
Par sadarb\u012bbu ar Grindeku<\/em> ir gandar\u012bts ar\u012b I. Kalvi\u0146\u0161. \u201cMani \u013coti iepriecina, ka Latvijas abi liel\u0101kie farmaceitiskie uz\u0146\u0113mumi ir akt\u012bvi s\u0101ku\u0161i ieguld\u012bt naudu p\u0113tniec\u012bb\u0101 \u2013 gan savos uz\u0146\u0113mumos, gan pas\u016bt\u012bt OSI.\u201d
Pal\u0113n\u0101m uzlabojas ar\u012b valsts attieksme. L\u012bdz \u0161im valsts attieksme bija nepareiza un mu\u013c\u0137\u012bga, bet beidzamaj\u0101 laik\u0101 tai ir tendence uzlaboties. P\u0113rn\u0101 gada vid\u016b s\u0101k\u0101s Valsts z\u0101\u013cu programma, kur zin\u0101tniekiem tiek dota nauda praktiski orient\u0113tiem p\u0113t\u012bjumiem. Pa\u0161laik tie ir 600 t\u016bkst. Ls visai programmai, no kuriem OSI sa\u0146em mazliet p\u0101ri 300 t\u016bkst. Ls. \u201cJa m\u0113s \u0161o naudu grib\u0113tu nopeln\u012bt, man b\u016btu j\u0101nodarbina 8 cilv\u0113ki, kas gadu str\u0101d\u0101tu vienai \u0101rzemju firmai. T\u0101tad visa valsts ir sasparojusies nofinans\u0113t asto\u0146us cilv\u0113kus!\u201d<\/p>\n\n\n\n